Australia produces an Alzheimer's vaccine

On December 9, scientists at Sydney Neurological Research Institute (BMRI) at the University of Sydney in Australia said they had successfully researched a vaccine that slows the development of Alzheimer's disease - a disease that causes dementia. due to neuronal degeneration - and other forms of dementia.

Scientists conducted experiments on mice with Alzheimer's disease and the results showed that the vaccine has the effect of preventing and reducing the ability to develop neurodegenerative plaques in the brain when acting on a protein that has Tau name.

Researcher Lars Ittner said this was the first vaccine to target Tau proteins effectively from the time of the disease.

The effect of preventing the disease is that the vaccine limits the progression of nerve degeneration, rather than eliminating them.

Australian researchers are collaborating with the US pharmaceutical industry to introduce this vaccine to human treatment.

Today, more than 35 million people in the world face diseases related to neuronal degeneration, with 269,000 people in Australia alone.